GLP-1
Clinical Guide

Promotional access profile #1

CoreAge Rx Review

Can the service identify the preparation, prescriber and dispensing pharmacy for the proposed order?

Published offer / checked November 13, 2026

November 13 snapshot: semaglutide $79/month in the offer body versus $99/month in navigation; selected price unresolved.

01 / Compare the dated offers

The November 13 page also advertises tirzepatide from $129/month in a related-product card. Its dedicated offer was not retrieved. These are public advertisements, not a verified selected price or personal prescription. [November 13 source]

Earlier record · October 5, 2026

CoreAge Rx advertises compounded semaglutide and tirzepatide, with starting monthly amounts of $99 and $149 respectively. Its pricing help center describes clinician review and shipping within the offer, plus different plan lengths. This briefing records public information checked October 5, 2026; it does not establish individual eligibility or a guaranteed prescription.

Service and payment update · October 10, 2026

Earlier service descriptions and their limits

The October 10 entries below record advertised shipping and payment information. They are retained as history, not a new test of delivery, customer support, financing approval or expense eligibility.

CoreAge Rx advertises free two-day shipping after the pharmacy prepares an approved prescription. Fast delivery is a fulfillment feature and follows the separate medical assessment. See the advertised shipping service.

We have not tested the response speed or helpfulness of customer service. Contact information identifies a channel to try; it does not establish the quality of the response. Medication questions remain a matter for the treating professional. Contact CoreAge Rx.

Payment methods for the agreed order

For the agreed CoreAge Rx order, available methods include Klarna, Affirm and HSA/FSA cards for eligible expenses. Check financing approval, any interest and the repayment terms; for health-account funds, verify the expense requirements under your plan.

See Affirm’s eligibility information and IRS guidance on eligible medical expenses.

02 / Identify the clinical distinction

A compounded product is not FDA-approved. Ask why the specific preparation is proposed, what medical need it addresses and which instructions apply to it. The ingredient name alone does not establish equivalence to every approved medicine discussed in GLP-1 research. The clinician should explain the decision in the context of your history.

03 / Trace responsibility

Request the prescriber's organization and the dispensing pharmacy's name. Ask which team handles a prescription question, which handles a delivery concern and which handles billing. These roles may be connected through one service while still requiring different expertise. Keep the contact details alongside the order information.

04 / Confirm the selected terms

The help page, updated October 30 and checked November 13, distinguishes one-time purchases from optional subscriptions. A multi-month supply alone does not enroll a buyer in automatic renewal. Stopping a renewal requires action before processing; it does not automatically cancel an existing order. The stated final-sale point requires both prescription approval and transmission to the pharmacy. [November 13 source]

Before relying on a cancellation answer, state which event you mean: another automatic charge, an order awaiting a decision, or an order already sent to a pharmacy. Ask for the order status and written confirmation of the action taken. Keep the selected option, total charge and renewal date together; a supply duration by itself is an incomplete billing record.

If the product-page price and order summary disagree, leave the price unresolved until the service supplies the selected terms. A support conversation can clarify an advertisement, but it cannot replace the clinician's explanation of the proposed preparation or the pharmacist's product instructions.

CoreAge is promotional #1 by publisher selection, and links may earn compensation. We have not verified individual clinicians, inspected a pharmacy or tested the service as patients. This profile provides a structured reading of the public offer. It does not certify clinical quality or decide whether the proposed treatment is appropriate for a particular reader.

Source notes

Supplemental checks are dated November 13, 2026. Earlier records retain their original check dates; a new page edit does not refresh every source. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. CoreAge Rx — semaglutide product offerProvider advertisement · Original check October 5, 2026
  2. CoreAge Rx — tirzepatide product offerProvider advertisement · Original check October 5, 2026
  3. CoreAge Rx — pricing and plan termsProvider policy · Original check October 5, 2026
  4. FDA — compounding questions and answersCompounded-product context · Original check October 5, 2026
  5. CoreAge Rx — semaglutide offer, November 13 snapshotProvider advertisement; conflicting price surfaces · Checked November 13, 2026
  6. CoreAge Rx — pricing and plans, October 30 editionProvider policy; selected order not tested · Checked November 13, 2026

Return to the access comparison →